Appropriate mineralocorticoid receptor antagonism and salt restriction are essential for primary aldosteronism therapy

Hypertens Res. 2023 Mar;46(3):794-796. doi: 10.1038/s41440-022-01155-0. Epub 2023 Jan 6.

Authors

Kosuke Sawami^{1

2}, Atsushi Tanaka³, Koichi Node⁴

Affiliations

¹ Department of Cardiovascular Medicine, Graduated School of Medicine, The University of Tokyo, Tokyo, Japan.
² Department of Cardiovascular Medicine, Saga University, Saga, Japan.
³ Department of Cardiovascular Medicine, Saga University, Saga, Japan. tanakaa2@cc.saga-u.ac.jp.
⁴ Department of Cardiovascular Medicine, Saga University, Saga, Japan. node@cc.saga-u.ac.jp.

PMID: 36609497
DOI: 10.1038/s41440-022-01155-0

No abstract available

Keywords: Mineralocorticoid receptor antagonism; Primary aldosteronism; Salt restriction.

Publication types

Editorial
Comment

MeSH terms

Humans
Hyperaldosteronism*
Mineralocorticoid Receptor Antagonists*
Receptors, Mineralocorticoid
Renin
Sodium Chloride
Sodium Chloride, Dietary

Substances

Mineralocorticoid Receptor Antagonists
Sodium Chloride, Dietary
Renin
Receptors, Mineralocorticoid
Sodium Chloride